Response to “Aspirin for Primary Prevention in Metabolic Dysfunction‐Associated Steatotic Liver Disease”
The data that support the findings of this study are available in the National Center for Health Statistics (NCHS)/NHANES at https://www.cdc.gov/nchs/nhanes/index.html. These data were derived from the following resources available in the public domain: - NHANES 2011–2018 public-use data, https://wwwn.cdc.gov/nchs/nhanes/- NCHS Public-Use Linked Mortality Files, https://www.cdc.gov/nchs/data-linkage/mortality-public.htm.
Authors
- Michael Charlton (ORCID: https://orcid.org/0000-0002-8766-7494)
- Mary E. Rinella
- Tsubasa Tsutsumi
- Takumi Kawaguchi
Institutions
- Kurume University (JP)
- University of Illinois Chicago (US)
- University of Chicago (US)
- Madrigal Pharmaceuticals (United States) (US)
Publication Details
- Journal
- Hepatology Research
- Published
- 2026-01-22
- DOI
- https://doi.org/10.1111/hepr.70123
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00